Terumo Blood and Cell Technologies' Peer-Reviewed Publication Shows Hollow Fiber-Based Bioreactors Can Produce 8x Viral Vector-Producing Cells in Four Days
Terumo Blood and Cell Technologies (Terumo BCT), a medical technology company, announced the publication of a peer-reviewed manuscript regarding a new protocol for automated expansion of HEK293T cells that are used to produce the viral vectors powering cell and gene therapies. The accepted manuscript, published ...
Source: pharmiweb.com